![Sara Elena Rebuzzi: Study protocol of the ongoing study on the first-line therapy in mRCC patients](https://oncodaily.com/pub/uploads/2024/06/R0upmaTU_400x400.png)
Photo taken from Sara Elena Rebuzzi/LinkedIn
Jul 1, 2024, 17:38
Sara Elena Rebuzzi: Study protocol of the ongoing study on the first-line therapy in mRCC patients
Sara Elena Rebuzzi, Medical Oncologis at The Hospital of San Paolo, made the following post on LinkedIn:
“Finally published the study protocol of the ongoing prospective/retrospective study on the first-line therapy in mRCC patients!! 520 patients enrolled, but the number is progressively increasing!!
DOI: 10.1186/s12885-024-12319-1.”
Source: Sara Elena Rebuzzi/LinkedIn
.
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023